BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4126316)

  • 1. Ultrastructural changes of mitochondria in dithranol-treated psoriatic epidermis.
    Swanbeck G; Lundquist PG
    Acta Derm Venereol; 1972; 52(2):94-8. PubMed ID: 4126316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline].
    Szczeklik-Franek A; Rubisz-Brzezińska JA; Grzybek H
    Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular changes in psoriatic and normal epidermis after treatment with ammonium mercuric chloride. Electron microscopy, tissue culture and neutron activation analyses.
    Frithz A
    Acta Derm Venereol Suppl (Stockh); 1971; 51():Suppl 66:1-20. PubMed ID: 5284815
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrastructural changes in psoriatic epidermis following anthralin treatment.
    Wilborn WH; Montes LF
    J Cutan Pathol; 1974; 1(3):132-50. PubMed ID: 4377841
    [No Abstract]   [Full Text] [Related]  

  • 5. Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
    Kanerva L
    Am J Dermatopathol; 1990 Feb; 12(1):51-62. PubMed ID: 2316816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental studies of the mechanism of action of chrysarobin and dithranol in psoriasis (evidence for a cytostatic effect on the epidermis)].
    Krebs A; Schaltegger H
    Dermatologica; 1965; 131(1):1-27. PubMed ID: 4284321
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytoplasmic and mitochondrial isoenzymes of malatedehydrogenase in psoriatic epidermis.
    Swanbeck G
    Acta Derm Venereol; 1971; 51(2):107-10. PubMed ID: 4101040
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current state and prospects of the use of cygnoline in the treatment of psoriasis].
    Ciesielska J
    Przegl Dermatol; 1985; 72(1):77-90. PubMed ID: 3892593
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcellular changes in keratin and granular cells of keratin-stripped and psoriatic epidermis revealed by scanning and transmission electron microscopy. Qualitative and quantitative analysis.
    Mishima Y; Matsunaka M; Nagao S
    Acta Derm Venereol Suppl (Stockh); 1973; 73():83-100. PubMed ID: 4521832
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoriasis--changes in surface microtopography.
    Tring C; Murgatroyd LB
    Arch Dermatol; 1975 Apr; 111(4):476-80. PubMed ID: 1122149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular changes in the psoriatic epidermis. 8. Observations on the submicroscopic cytoplasmic differentiation of epidermal cells of primary tissue cultures from psoriatic lesions treated in vivo with ammoniated mercury.
    Frithz A
    Acta Derm Venereol; 1970; 50(6):419-30. PubMed ID: 4099151
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of cignolin on DNA synthesis in the epidermis].
    Born W
    Hautarzt; 1969 Apr; 20(4):178-81. PubMed ID: 5375474
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations].
    Braun-Falco O; Burg G; Schoefinius HH
    Arch Dermatol Forsch; 1971; 241(3):217-36. PubMed ID: 4398688
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new Cologne therapy scheme--addition of tar to cignoline-salicylic acid-white vaseline therapy in psoriasis vulgaris].
    Steigleder GK; Schulze HJ
    Z Hautkr; 1984 Feb; 59(3):188, 191-2. PubMed ID: 6719977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
    Göring HD; Voss M
    Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular changes in the psoriatic epidermis. VI. The submicroscopic intracellular distribution of mercury compound in the normal epidermis in comparison with that in the psoriatic epidermis.
    Frithz A; Lagerholm B
    Acta Derm Venereol; 1968; 48(5):403-12. PubMed ID: 4177563
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular changes in the psoriatic epidermis. II. The submicroscopic organization in psoriatic lesions of different age.
    Lagerholm B
    Acta Derm Venereol; 1965; 45(2):99-122. PubMed ID: 4163231
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular changes in the psoriatic epidermis. VII. The influence of mercury compound on the submicroscopic differentiation of psoriatic epidermal cells.
    Frithz A; Lagerholm B
    Acta Derm Venereol; 1969; 49(3):221-32. PubMed ID: 4184269
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular changes in the psoriatic epidermis. V. The submicroscopic intracellular distribution of mercury compound in the psoriatic epidermis.
    Lagerholm B; Frithz A
    Acta Derm Venereol; 1967; 47(4):222-36. PubMed ID: 4166057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.